Allscripts Healthcare Solutions Inc (MDRX) Given Average Rating of “Hold” by Analysts

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has been given an average recommendation of “Hold” by the fifteen ratings firms that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $15.45.

A number of equities research analysts have recently weighed in on MDRX shares. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Thursday, October 4th. Cantor Fitzgerald restated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Thursday, August 2nd. ValuEngine upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, July 14th. Canaccord Genuity lowered their price objective on Allscripts Healthcare Solutions from $17.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, August 3rd. Finally, SunTrust Banks downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Friday.

Shares of NASDAQ MDRX opened at $9.76 on Monday. Allscripts Healthcare Solutions has a twelve month low of $9.52 and a twelve month high of $16.13. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 1.41. The company has a market capitalization of $2.08 billion, a PE ratio of 23.82, a PEG ratio of 1.58 and a beta of 1.34.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings results on Thursday, November 1st. The software maker reported $0.13 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.14 by ($0.01). Allscripts Healthcare Solutions had a net margin of 0.10% and a return on equity of 8.26%. The firm had revenue of $536.00 million during the quarter, compared to the consensus estimate of $546.09 million. During the same quarter last year, the firm posted $0.15 earnings per share. Allscripts Healthcare Solutions’s revenue was up 18.8% compared to the same quarter last year. On average, equities analysts forecast that Allscripts Healthcare Solutions will post 0.56 EPS for the current year.

Allscripts Healthcare Solutions declared that its board has initiated a stock buyback program on Thursday, August 2nd that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the software maker to buy up to 11.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

In other news, EVP Brian Farley sold 6,000 shares of the stock in a transaction on Friday, September 14th. The stock was sold at an average price of $14.67, for a total value of $88,020.00. Following the completion of the transaction, the executive vice president now owns 242,673 shares of the company’s stock, valued at $3,560,012.91. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Dennis Olis sold 25,000 shares of the stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $14.50, for a total value of $362,500.00. The disclosure for this sale can be found here. Corporate insiders own 0.75% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its stake in shares of Allscripts Healthcare Solutions by 3.6% in the second quarter. Dimensional Fund Advisors LP now owns 10,445,549 shares of the software maker’s stock worth $125,347,000 after purchasing an additional 367,072 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 10.7% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 6,836,652 shares of the software maker’s stock valued at $82,040,000 after buying an additional 658,123 shares during the period. Dalton Greiner Hartman Maher & Co. lifted its holdings in shares of Allscripts Healthcare Solutions by 2.3% in the third quarter. Dalton Greiner Hartman Maher & Co. now owns 3,248,685 shares of the software maker’s stock valued at $46,294,000 after buying an additional 74,174 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of Allscripts Healthcare Solutions by 15.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 2,159,300 shares of the software maker’s stock valued at $25,912,000 after buying an additional 285,000 shares during the period. Finally, Paradigm Capital Management Inc. NY lifted its holdings in shares of Allscripts Healthcare Solutions by 4.2% in the second quarter. Paradigm Capital Management Inc. NY now owns 2,061,900 shares of the software maker’s stock valued at $24,743,000 after buying an additional 82,600 shares during the period.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Story: Penny Stocks

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply